Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blood

Showing results (821-830 of 50,530) with videos related to

Pageof 5,053
Sort By:
Blood|March 3, 2022
It takes T to tango: immunotherapy in MMVikas A Gupta, Madhav V Dhodapkar
Blood|July 1, 1986
Expression of p53 in human leukemia and lymphomaM Prokocimer, M Shaklai, H B Bassat, et al.
Blood|February 14, 2022
Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC-transplanted SCID patients with IL2RG/JAK3 deficiencyPedro Goncalves, Jean-Marc Doisne, Toshiki Eri, et al.
Blood|February 15, 2022
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trialMatthew J Frigault, Jorg Dietrich, Kathleen Gallagher, et al.
Blood|April 1, 1988
Erythrocyte glycolysis and its marked alterations by muscular exercise in type VII glycogenosisT Shimizu, N Kono, H Kiyokawa, et al.
Blood|April 1, 1988
Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemiaJ M Rowe, A Y Chang, J M Bennett
Blood|May 16, 2018
Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 studyRegis Peffault de Latour, Sylvie Chevret, Charlotte Jubert, et al.
Blood|May 17, 2018
A common <i>TCN1</i> loss-of-function variant is associated with lower vitamin B<sub>12</sub> concentration in African AmericansYao Hu, Laura M Raffield, Linda M Polfus, et al.
Blood|May 18, 2018
Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with <i>TP53</i> mutationsStefan O Ciurea, Abhishek Chilkulwar, Rima M Saliba, et al.
Blood|September 1, 1985
Monoclonal antibody-mediated cytotoxicity of human myeloid leukemia cells: an in vitro model for estimating efficiency and optimal conditions for cytolysisA L Howell, E D Ball
Pageof 5,053

Showing results (821-830 of 50,530) with videos related to

Sort By:
Pageof 5,053
Blood|March 3, 2022
It takes T to tango: immunotherapy in MMVikas A Gupta, Madhav V Dhodapkar
Blood|July 1, 1986
Expression of p53 in human leukemia and lymphomaM Prokocimer, M Shaklai, H B Bassat, et al.
Blood|February 14, 2022
Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC-transplanted SCID patients with IL2RG/JAK3 deficiencyPedro Goncalves, Jean-Marc Doisne, Toshiki Eri, et al.
Blood|February 15, 2022
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trialMatthew J Frigault, Jorg Dietrich, Kathleen Gallagher, et al.
Blood|April 1, 1988
Erythrocyte glycolysis and its marked alterations by muscular exercise in type VII glycogenosisT Shimizu, N Kono, H Kiyokawa, et al.
Blood|April 1, 1988
Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemiaJ M Rowe, A Y Chang, J M Bennett
Blood|May 16, 2018
Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 studyRegis Peffault de Latour, Sylvie Chevret, Charlotte Jubert, et al.
Blood|May 17, 2018
A common <i>TCN1</i> loss-of-function variant is associated with lower vitamin B<sub>12</sub> concentration in African AmericansYao Hu, Laura M Raffield, Linda M Polfus, et al.
Blood|May 18, 2018
Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with <i>TP53</i> mutationsStefan O Ciurea, Abhishek Chilkulwar, Rima M Saliba, et al.
Blood|September 1, 1985
Monoclonal antibody-mediated cytotoxicity of human myeloid leukemia cells: an in vitro model for estimating efficiency and optimal conditions for cytolysisA L Howell, E D Ball
Pageof 5,053